Averitas Pharma News and Activities

Averitas Pharma is owned by Grunenthal. Grunenthal has a direct presence in 5 countries.

Grunenthal has 5 subsidiaries including Averitas Pharma, Grunenthal France and Grunenthal Italy.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 6 main executives

Most searched biographies at Averitas Pharma

• Arvashni Seeripat, President
• Victor Gialanella, Vice President, Head of Commercial Excellence
• Felipe Pradilla, Commercial Finance Director

Create your alert
to follow the executive moves at Averitas Pharma.

Grunenthal has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Averitas Pharma

Social media about Averitas Pharma

• Averitas Pharma on Wikipedia, Google News & Yahoo Finance
• Averitas Pharma on LinkedIn, X (Twitter) & YouTube